Form 8-K - Current report:
SEC Accession No. 0001193125-22-267232
Filing Date
2022-10-24
Accepted
2022-10-24 09:17:41
Documents
38
Period of Report
2022-10-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d412446d8k.htm   iXBRL 8-K 22801
2 EX-99.1 d412446dex991.htm EX-99.1 23516
6 GRAPHIC g412446ex99_1p10g1.jpg GRAPHIC 253607
7 GRAPHIC g412446ex99_1p11g1.jpg GRAPHIC 223119
8 GRAPHIC g412446ex99_1p12g1.jpg GRAPHIC 189804
9 GRAPHIC g412446ex99_1p13g1.jpg GRAPHIC 257674
10 GRAPHIC g412446ex99_1p14g1.jpg GRAPHIC 244153
11 GRAPHIC g412446ex99_1p15g1.jpg GRAPHIC 238283
12 GRAPHIC g412446ex99_1p16g1.jpg GRAPHIC 255782
13 GRAPHIC g412446ex99_1p17g1.jpg GRAPHIC 195512
14 GRAPHIC g412446ex99_1p18g1.jpg GRAPHIC 250845
15 GRAPHIC g412446ex99_1p19g1.jpg GRAPHIC 257429
16 GRAPHIC g412446ex99_1p1g1.jpg GRAPHIC 467056
17 GRAPHIC g412446ex99_1p20g1.jpg GRAPHIC 207883
18 GRAPHIC g412446ex99_1p21g1.jpg GRAPHIC 291676
19 GRAPHIC g412446ex99_1p22g1.jpg GRAPHIC 216398
20 GRAPHIC g412446ex99_1p23g1.jpg GRAPHIC 199730
21 GRAPHIC g412446ex99_1p24g1.jpg GRAPHIC 161355
22 GRAPHIC g412446ex99_1p25g1.jpg GRAPHIC 378805
23 GRAPHIC g412446ex99_1p2g1.jpg GRAPHIC 810260
24 GRAPHIC g412446ex99_1p3g1.jpg GRAPHIC 287567
25 GRAPHIC g412446ex99_1p4g1.jpg GRAPHIC 239815
26 GRAPHIC g412446ex99_1p5g1.jpg GRAPHIC 300223
27 GRAPHIC g412446ex99_1p6g1.jpg GRAPHIC 261151
28 GRAPHIC g412446ex99_1p7g1.jpg GRAPHIC 291713
29 GRAPHIC g412446ex99_1p8g1.jpg GRAPHIC 259515
30 GRAPHIC g412446ex99_1p9g1.jpg GRAPHIC 277532
  Complete submission text file 0001193125-22-267232.txt   9846885

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA glue-20221024.xsd EX-101.SCH 2858
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE glue-20221024_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glue-20221024_pre.xml EX-101.PRE 11709
32 EXTRACTED XBRL INSTANCE DOCUMENT d412446d8k_htm.xml XML 3472
Mailing Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210
Business Address 645 SUMMER STREET SUITE 102 BOSTON MA 02210 617-949-2643
Monte Rosa Therapeutics, Inc. (Filer) CIK: 0001826457 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40522 | Film No.: 221324943
SIC: 2836 Biological Products, (No Diagnostic Substances)